Richard Ginn - 31 Dec 2023 Form 5 Insider Report for Tenon Medical, Inc. (TNON)

Role: Chief Technology Officer, Director
Signature: /s/ Richard Ginn
Issuer symbol: TNON
Transactions as of: 31 Dec 2023
Net transactions value: +$10,578
Form type: 5
Filing time: 13 Feb 2024, 16:47:55 UTC
Previous filing: 24 May 2023
Next filing: 15 Oct 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNON	Common Stock	Conversion of derivative security	$15,182	+7,516	+11%	$2.02	73,265	22 Nov 2023	Direct	F1
transaction	TNON	Common Stock	Tax liability	$4,604	-2,302	-3.1%	$2.00	70,963	27 Nov 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TNON	Restricted Stock Units						22,551	31 Dec 2023	Common Stock	22,551		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of common stock were issued pursuant to the vesting of Restricted Stock Units.
F2	These shares were sold to pay tax liability associated with the vesting of Restricted Stock Units.
F3	Each Restricted Stock Unit represents the right to receive one share of Common Stock. These units are on a 3 year vesting schedule, for the first year they vest on an annual basis and thereafter they vest on a semi-annual basis. 45,098 (post-split) Restricted Stock Units were initially granted on May 12, 2022. 22,547 Restricted Stock Units vested as of December 31, 2023.